when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

Immunology · news · pharmadog

← back to Immunology

News · Immunology

413 stories

May 12, 26Sequencing Strategies After Progression in Multiple Myelomaonclive

May 12, 26EGFR-Mutated NSCLC: Targeting MET-Driven Resistance in Second-Line Therapyonclive

May 12, 26Sequencing ADCs in Endometrial Canceronclive

May 12, 26Second Clinical Scenario - Progressive Disease Despite Hematocrit Controlonclive

May 12, 26STAT+: Despite its toll, alcohol is still an awkward subject in the doctor’s officestat

May 12, 26STAT+: Alcohol is wreaking havoc on U.S. public health. American society looks the other waystat

May 12, 266 takeaways from STAT’s investigation into the U.S. alcohol epidemicstat

May 12, 26STAT+: Bristol Myers Squibb partners with China’s Hengrui Pharma on a dozen drugsstat

May 11, 26Dr Silbermann on Clinical Trial Design Considerations in Multiple Myelomaonclive

May 11, 26MimiVax and Roswell Park Open Phase 2 Trial of SurVaxM for Patients with Metastatic Neuroendocrine Tumorsonclive

May 11, 26Inhibrx delivers ‘differentiated’ cancer drug data; Fractyl starts diabetes gene therapy trialbiopharma dive

May 11, 26Dr Randall on the Rationale for Investigating CSF-1R Inhibition in TGCTonclive

May 11, 26Renal Cell Carcinoma: Real-World Factors in First-Line Treatment Selectiononclive

May 11, 26Expanding ctDNA Applications to RCC and Germ Cell Tumorsonclive

May 11, 26RAPNO Criteria and MRI Assessment in PLGG: Recommendations vs. Real-World Practiceonclive

May 11, 26ctDNA in Metastatic Urothelial Carcinomaonclive

May 11, 26Institutional Perspectives on Treatment Thresholds in PLGGonclive

May 11, 26Renal Cell Carcinoma: Practical Treatment Selection Across Risk Groupsonclive

May 11, 26Animal skin disease confirmed in clusters of European men who have sex with menstat

May 10, 26Five Under 5: Top Oncology Videos for the Week of 5/3onclive

May 9, 26The OncFive: Top Oncology Articles for the Week of 5/3onclive

May 8, 26Dr Randall on Long-Term Responses and Functional Benefits With Pimicotinib in TGCTonclive

May 8, 26Post–T-DXd Sacituzumab Govitecan Plus Trastuzumab Yields Low ORR in HER2+ Metastatic Breast Canceronclive

May 8, 26Dr Sznol on the Nuances of Recommending Neoadjuvant Therapy in Metastatic Melanomaonclive

May 8, 26Biomarker-Directed Therapies Move the GI Oncology Paradigm Beyond a One-Size-Fits-All Approach: With Michael J. Pishvaian, MD, PhDonclive

May 8, 26Capivasertib/Fulvestrant Yields Numerical OS Advantage in PIK3CA/AKT1/PTEN–Altered Breast Canceronclive

May 8, 26FDA Approves Zenocutuzumab for NRG1 Fusion+ Cholangiocarcinomaonclive

May 8, 26UT MD Anderson Shares Latest Research Breakthroughsonclive

May 8, 26Giants of Cancer Care Announces the 14th Annual Class of Inducteesonclive

May 8, 26OncLive Weekly News Quiz (5/8/2026): Test Your Knowledge on Key Breast, Lung, and Pancreatic Cancer Updatesonclive

← prevpage 11 of 14next →